Report Description

United States cardiology surgical and interventional devices market is expected to witness healthy CAGR during the forecast period. Key factors fueling the growth of United States cardiology surgical and interventional devices market include continuous technological advancements in surgical and interventional cardiology devices, growing geriatric population and rising cases of coronary artery diseases. Furthermore, launch of effective, advanced and easy-to-use cardiology surgical and interventional cardiology devices is fostering the growth of market in United States. With increasing expenditure on healthcare and growing emphasis on effective, accurate, and early treatment of target diseases, the market is expected to undergo significant growth in coming years.

Additionally, advancements in medical devices have led to introduction of bioabsorble stents and new generation celect platinum IVC (inferior vena cava) filter, which are gaining huge traction in United States cardiology surgical and interventional devices market. The country is also witnessing rising prevalence of cardiovascular diseases, which is acting as one of the major factors behind growing demand for cardiology surgical and interventional devices.

United States cardiology surgical and interventional devices market can be categorized based on product type, surgical approach, type of cardiac surgery, end user and region. Based on product type, the market can be segmented into cardiovascular surgical devices and interventional devices. The cardiovascular surgical devices segment is further split into beating heart surgery system, cardiac ablation devices, cardiopulmonary bypass equipment, perfusion disposables and others. The interventional devices segment is further categorized into artereotomy closure devices, cardiac catheters, coronary guidewires, coronary stents and intravascular ultrasound systems. Among them, the interventional devices are expected to register fastest growth through 2027 owing to their growing application in cardiology surgery.

Major players operating in the United States cardiology surgical and interventional devices market include Biosense Webster, Inc., Boston Scientific Corporation, C.R. Bard, Inc., Edwards Lifesciences Corp., Medtronic. Inc., Cardinal Health Inc., Abbott Laboratories Inc., Terumo Medical Corporation, Becton Dickinson and Company and Johnson & Johnson, among others. The companies are investing on launching novel products and are undertaking growth strategies such as mergers & acquisitions and collaborations.

Objective of the Study:

  • To analyze and estimate the market size of United States cardiology surgical and interventional devices market from 2017 to 2020.
  • To estimate and forecast the market size of United States cardiology surgical and interventional devices market from 2021 to 2027 and growth rate until 2027.
  • To classify and forecast United States cardiology surgical and interventional devices market based on product type, surgical approach, type of cardiac surgery, end user, company and regional distribution.
  • To identify dominant region or segment in the United States cardiology surgical and interventional devices market.
  • To identify drivers and challenges for United States cardiology surgical and interventional devices market.
  • To examine competitive developments such as expansions, mergers & acquisitions, etc., in United States cardiology surgical and interventional devices market.
  • To conduct pricing analysis for United States cardiology surgical and interventional devices market.
  • To identify and analyze the profile of leading players operating in United States cardiology surgical and interventional devices market.
  • To identify key sustainable strategies adopted by market players in United States cardiology surgical and interventional devices market.


Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of cardiology surgical and interventional device manufacturers across United States. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers who could not be identified due to the limitations of secondary research. TechSci Research analyzed the presence of all major players across United States.

TechSci Research calculated the market size of United States cardiology surgical and interventional devices market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these services and end users for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Cardiology surgical and interventional devices manufacturers, suppliers, distributors and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to cardiology surgical and interventional devices
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as cardiology surgical and interventional device manufacturers, suppliers, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Attribute

Details

Base Year

2021

Historical Years

2017 – 2020

Estimated Year

2022E

Forecast Period

2023F – 2027F

Quantitative Units

Revenue in USD Million, and CAGR for 2017-2021 and 2022E-2027F

Report Coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered

  • Type
  • Surgical Approach
  • Type of Cardiac Surgery
  • End User

Region Scope

South-Region, West-Region, Mid-West Region & Northeast-Region

Key Companies Profiled

Biosense Webster, Inc., Boston Scientific Corporation, C.R. Bard, Inc., Edwards Lifesciences Corp., Medtronic. Inc., Cardinal Health Inc., Abbott Laboratories Inc., Terumo Medical Corporation, Becton Dickinson and Company and Johnson & Johnson.

Customization Scope

10% free report customization with purchase. Addition or alteration to regional & segment scope.

Pricing and Purchase Options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Report Scope:

In this report, United States cardiology surgical and interventional devices market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • United States Cardiology Surgical and Interventional Devices Market, By Type:
    • Cardiovascular Surgical Devices
      • Beating Heart Surgery System
      • Cardiac Ablation Devices
      • Cardiopulmonary Bypass Equipment
      • Perfusion Disposables
      • Others
    • Interventional Devices
      • Artereotomy Closure Devices
      • Cardiac Catheters
      • Coronary Guidewires
      • Coronary Stents
      • Intravascular Ultrasound Systems
  • United States Cardiology Surgical and Interventional Devices Market, By Surgical Approach:
    • Open-Heart Surgery
    • Off-Pump Heart Surgery
    • Minimally Invasive Heart Surgery
  • United States Cardiology Surgical and Interventional Devices Market, By Type of Cardiac Surgery:
    • Coronary Artery Bypass Grafting (CABG)
    • Transmyocardial Laser Revascularization (TMR)
    • Heart Valve Repair or Replacement
    • Heart Transplant
    • Arrhythmia Treatment
    • Others
  • United States Cardiology Surgical and Interventional Devices Market, By End User:
    • Hospitals & Clinics
    • Ambulatory Surgical Centers
    • Others
  • United States Cardiology Surgical and Interventional Devices Market, By Region:
    • North-East
    • Mid-West
    • West
    • South

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in United States cardiology surgical and interventional devices market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Profit Margin Analysis

  • Profit margin analysis in case of direct and indirect sales channel.

It is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on United States Cardiology Surgical and Interventional Devices Market

4.    Executive Summary

5.    Voice of Customer

6.    United States Cardiology Surgical and Interventional Devices Market Outlook

6.1.  Market Size & Forecast

6.1.1. By Value & Volume

6.2.  Market Share & Forecast

6.2.1.     By Product Type (Cardiovascular Surgical Devices (Beating Heart Surgery System, Cardiac Ablation Devices, Cardiopulmonary Bypass Equipment, Perfusion Disposables, Others), Interventional Devices (Artereotomy Closure Devices, Cardiac Catheters, Coronary Guidewires, Coronary Stents, Intravascular Ultrasound Systems))

6.2.2.     By Surgical Approach (Open-Heart Surgery, Off-Pump Heart Surgery, Minimally Invasive Heart Surgery)

6.2.3.     By Type of Cardiac Surgery (Coronary Artery Bypass Grafting (CABG), Transmyocardial Laser Revascularization (TMR), Heart Valve Repair or Replacement, Heart Transplant, Arrhythmia Treatment, Others)

6.2.4.     By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Others)

6.2.5.     By Region

6.2.6.     By Company

6.3.  Product Market Map

7.    United States Cardiovascular Surgical Devices Market Outlook

7.1.  Market Size & Forecast

7.1.1. By Value & Volume

7.2.  Market Share & Forecast

7.2.1.     By Type (Cardiac Ablation Devices, Cardiopulmonary Bypass Equipment, Perfusion Disposables)

7.2.2.     By Surgical Approach

7.2.3.     By Type of Cardiac Surgery

7.2.4.     By End User

8.    United States Interventional Devices Market Outlook

8.1.  Market Size & Forecast

8.1.1. By Value & Volume

8.2.  Market Share & Forecast

8.2.1.     By Type (Artereotomy Closure Devices, Cardiac Catheters, Coronary Guidewires, Coronary Stents, Intravascular Ultrasound Systems (IVUS), Percutaneous Transluminal Coronary Balloons (PTCA), PTCA Coronary Drug Eluting Balloons)

8.2.2.     By Surgical Approach

8.2.3.     By Type of Cardiac Surgery

8.2.4.     By End User

9.    Market Dynamics

9.1.  Drivers

9.2.  Challenges

10.  Market Trends & Development

11.  Policy & Regulatory Landscape

12.  Import Export Analysis

13.  United States Economic Profile

14.  Competitive Landscape

14.1.              Competition Outlook

14.2.              Company Profiles

14.2.1.  Biosense Webster, Inc.

14.2.2.  Boston Scientific Corporation

14.2.3.  C.R. Bard, Inc.

14.2.4.  Edwards Lifesciences Corp.

14.2.5.  Medtronic. Inc.

14.2.6.  Cardinal Health Inc.

14.2.7.  Abbott Laboratories Inc.

14.2.8.  Terumo Medical Corporation

14.2.9.  Becton Dickinson and Company

14.2.10.                Johnson & Johnson

15.  Strategic Recommendations

(Note: The companies list can be customized based on the client requirements.)

Figures and Tables

Frequently asked questions

down-arrow

Biosense Webster, Inc., Boston Scientific Corporation, C.R. Bard, Inc., Edwards Lifesciences Corp., Medtronic. Inc., Cardinal Health Inc., Abbott Laboratories Inc., Terumo Medical Corporation, Becton Dickinson and Company, and Johnson & Johnson are the leading market players in the United States Cardiology Surgical and Interventional Devices Market.

down-arrow

The United States Cardiology Surgical and Interventional Devices Market is divided into product type, surgical approach, type of cardiac surgery, end user, company and regional distribution.

down-arrow

Based on product type, the market can be segmented into cardiovascular surgical devices and interventional devices. Cardiovascular surgical devices are expected to hold the largest market during the forecast period.

down-arrow

The growing healthcare industry, well-developed healthcare infrastructure, and ongoing technological advancements drive the demand for the United States Cardiology Surgical and Interventional Devices Market during the forecast period.

profile

Sakshi Bajaal

Business Consultant
Press Release

United States Cardiology Surgical and Interventional Devices Market to Witness Substantial Growth through 2025

Oct, 2020

Increasing prevalence of cardiovascular diseases to fuel the growth of United States cardiology surgical and interventional devices market